Types segmentation classifies therapeutic approaches that form the Drug Addiction Therapy market, each with unique cost and efficacy characteristics. Medication‑Assisted Treatment (MAT) pairs drugs such as buprenorphine, methadone, or naltrexone with counseling; recurring medication fees and monitoring make MAT the largest revenue driver, about 40 % of market size. Behavioral Therapy includes sub‑modalities—Cognitive‑Behavioral Therapy (CBT), Motivational Interviewing (MI), and Contingency Management (CM). CBT, focused on restructuring thought patterns, contributes roughly 15 % of revenue, while MI adds 10 % through brief client‑centered sessions. CM, which offers incentives for abstinence, holds a modest 5 % share but is gaining traction under outcome‑based reimbursement. Holistic and Complementary Therapies such as mindfulness‑based relapse prevention and acupuncture account for the remaining 30 % of the market, reflecting rising consumer preference for non‑pharmacologic options. This Drug Addiction Therapy segmentation by type clarifies the relative financial impact of each therapeutic class within the overall market.